[Skip to Content]
[Skip to Content Landing]
Invited Commentary
June 26, 2019

The Medical Hospital Readmission Reduction Program: Does It Do Any Good?

Author Affiliations
  • 1Kellogg School, Northwestern University, Evanston, Illinois
  • 2Department of Economics, Harvard University, Cambridge, Massachusetts
  • 3National Bureau of Economic Research, Cambridge, Massachusetts
JAMA Intern Med. 2019;179(9):1174-1175. doi:10.1001/jamainternmed.2019.1003

One of the largest experiments in health care payments in recent years is the Hospital Readmission Reduction Program (HRRP), a provision of the Affordable Care Act. Roughly 20% of Medicare admissions lead to a readmission within 30 days, and many readmissions are considered prima facie evidence of poor care. Historically, readmissions were a source of revenue for hospitals but a large cost for the Medicare program. The HRRP cut hospitals’ Medicare inpatient payments as a penalty for high readmission rates on targeted conditions.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words